Lynas Rare Earths Limited

Management described FY26 as a “wonderful improvement” in results, driven by higher market prices, a sales premium, and slightly higher product volumes, but did not state revenue, EPS, or gross margin figures in the call. On costs, CFO Gaudenz Sturzenegger said G&A rose by $34 million, including $23 million of underabsorbed costs tied to the Kalgoorlie ramp that should unwind as operations fully ramp, and about $10 million of other G&A, more than half of which was explained by leadership-change costs. He also said sulfuric acid costs are about 4x higher than 12 months ago, but may moderate in a couple of months. For FY27, management said output should be “fairly higher” than FY26, with growth constrained more by industrial execution, concentrate quality, and the need to raise the Malaysian cracking allowance to 110 than by demand.

Interim CEO Pol Le Roux framed Lynas as “personal” and centered on an experienced team, strong R&D, and the company’s ability to fix problems and prepare for future markets. He said FY26 was about “harvesting” existing projects and that Lynas is now ready to “grow,” citing improved operations at Mt Weld, Kalgoorlie and Kuantan, plus progress on DyTb, samarium and downstream partnerships. His tone was confident and upbeat, but he repeatedly stressed discipline, saying growth must be executed carefully and that the company is focused on quality, reliability and non-China supply chain development.

Gaudenz Sturzenegger focused on near-term cost dynamics and said the current fixed-cost base should ease over time rather than be treated as the right run rate. He quantified the G&A increase at $34 million, with $23 million of underabsorbed costs expected to reverse as Kalgoorlie ramps, and called roughly $10 million of other G&A largely one-off, linked in part to leadership change. He also flagged sulfuric acid as the main adverse cost item, saying it is about 4x above the level 12 months ago, though he expects possible moderation within a couple of months. On capital allocation, management said the reported capex reflects only clearly decided investments, while larger projects are still being assessed and therefore not yet included.

Analysts pressed management on FY27 production, costs, capital allocation and new offtake. Management repeatedly declined to give specific production numbers, but said FY27 NdPr output should be “pretty high” and that volume growth depends on ramping Mt Weld, Kalgoorlie and LAMP efficiently, plus increasing the Malaysian cracking allowance to 110. On capital deployment, management said the $900 million-plus equity raise was intended to fund the next five years through 2030, and that only decided projects such as heavy rare earth separation and smaller quick-win capex are reflected so far. On downstream strategy and competitors, Pol said more offtakes are in discussion, competition is welcome, and Lynas is focused on execution rather than how rival alliances are structured.